Vionexus
NDC Package 55443-0401-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vionexus is a . Marketed by Metrex Research, Llc, this product is identified by NDC 55443-0401 and is authorized under FDA application part333A.

Identification & Billing

NDC Package Code
55443-0401-2
Package Description
12 BOTTLE, SPRAY in 1 CASE / 237 mL in 1 BOTTLE, SPRAY (55443-0401-1)
Product Code
11-Digit Billing Format
55443040102

Clinical Specifications

Proprietary Name
Vionexus
Dosage Form
-

Regulatory & Marketing

Labeler Name
Metrex Research, Llc
FDA Application #
part333A
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-30-2020
End Marketing Date
04-01-2022
Listing Expiration
04-01-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55443-0401). Click a package code to view its specific billing and regulatory data.

12 BOTTLE, WITH APPLICATOR in 1 CASE / 710 mL in 1 BOTTLE, WITH APPLICATOR (55443-0401-3)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55443-0401-2 identifies a specific commercial package of 12 bottle, spray in 1 case / 237 ml in 1 bottle, spray (55443-0401-1) of Vionexus, labeled by Metrex Research, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Metrex Research, Llc on March 30, 2020. The current certification is valid through April 01, 2022.

How is this Metrex Research, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55443040102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55443-0401-2
11-Digit CMS (5-4-2)
55443-0401-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.